UBE2C and non-small cell lung carcinoma: These results suggest that knockdown of ZEB1/2 inhibits UBE2C-dependent cellular growth and invasiveness and UBE2C-mediated EMT progress by promoting ZEB1/2 expression in DDP-resistant NSCLC cells.